Elbow joint is a type of hinge joint which is composed of two articulations. One articulation is humeroulnar joint which is formed when trochlear of the humerus articulates with trochlear notch of the ulna. Another articulation is humeroradial joint which is formed when capitulum of the humerus is joined with the head of the radius.

Question

Want to see the full answer?

Answer 1

Question

Chapter 9, Problem 2CAL

Summary Introduction

Introduction:

Elbow joint is a type of hinge joint which is composed of two articulations. One articulation is humeroulnar joint which is formed when trochlear of the humerus articulates with trochlear notch of the ulna. Another articulation is humeroradial joint which is formed when capitulum of the humerus is joined with the head of the radius.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

A pharmaceutical company has developed a new weight loss drug for adults. Preliminary tests show that the drug seems to be fairly effective in about 75% of test subjects. The drug company thinks that the drug might be most effective in overweight individuals, but they are unsure to whom they should market the product. Use the scientific method to address the pharmaceutical company’s needs: State a research question that addresses the pharmaceutical company's problem Conduct online research on “Body Mass Index” categories and record a brief summary Construct a testable hypothesis and record in Design an experiment to test the hypothesis and describe the procedures, variables, and data to be collected What is the purpose of a control group in an experiment? What would the control groups be for each of your designed experiments in this exercise? Describe the data that would be recorded in each of the experiments you designed. Would it be classified as quantitative or…

Patients with multiple sclerosis frequently suffer from blurred vision. Drug X was developed to reduce blurred vision in healthy patients, but the effectiveness had not been tested on those suffering from multiple sclerosis. A study was conducted to determine if Drug X is effective at reducing blurry vision in multiple sclerosis patients. To be considered effective, a drug must reduce blurred vision by more than 30% in patients. Researchers predicted that a 20 mg dose of the drug would be effective for treating blurred vision in multiple sclerosis patients by reducing blurred vision by more than 30%. Drug X was administered to groups of multiple sclerosis patients at three doses (10 mg/day, 20 mg/day, 30 mg/day) for three weeks. A fourth group of patients was given a placebo containing no drug X for the same length of time. Vision clarity was measured for each patient before and after the three-week period using a standard vision test. The results were analyzed and graphed (See Figure…

Svp je voulais demander l aide pour mon exercice